Table 2. Curcumin (Cur) alleviated DM-induced left ventricular disfunction.
Group | Heart rate (bpm) | IVSD(mm) | LVEDD(mm) | LVESD(mm) | FS(%) | EF(%) |
Control | 378±11 | 1.32±0.07 | 2.78±0.12 | 1.53±0.12 | 45.1±2.5 | 82.4±2.3 |
DM | 308±15* | 1.88±0.11* | 3.35±0.30 | 2.25±0.24* | 33.1±3.8* | 68.5±5.2* |
DM+Cur100 mg/kg | 330±13 | 1.36±0.08# | 2.72±0.16 | 1.82±0.12 | 36.7±3.2 | 76.6±2.9 |
DM+Cur200 mg/kg | 364±17# | 1.35±0.08# | 2.85±0.20 | 1.60±0.15# | 44.0±2.8# | 81.8±2.7# |
IVSD, interventricular septal diastolic wall thickness; LVEDD, left ventricular end diastolic diameter; LVESD, left ventricular end systolic diameter; FS, fractional shortening = [(LVEDD-LVESD)/LVEDD] ×100%; EF, ejection fraction = [(LVEDD3-LVESD3)/LVEDD3] ×100%. Data are means ± SEM;
P<0.05 vs control group;
P<0.05 vs DM group; n = 6 per group.